Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

248.25
-2.7880-1.11%
Number of Gainers:2
Number of Losers:13
Number of Flat:1
PE:- -
High:251.06
Open:251.03
Low:245.08
Close:251.04
Volume:25.50M
Turnover:344.10M
Market Cap:61.29B
Float Cap:54.04B

Loading ...

Dr. Reddy's Laboratories Advances Friday, Underperforms Market

Dow Jones
·
Sep 25

NYSE Order Imbalance 23191.0 Shares on Buy Side

THOMSON REUTERS
·
Sep 25

Cronos Hosts 2026 Investor Day

GlobeNewswire
·
Sep 24

Shenzhen's Rise of a Premier Super CBD

Deep News
·
Sep 24

Aurora files application with ASC over Curaleaf bid deficiencies

TIPRANKS
·
Sep 24

Press Release: Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure

Dow Jones
·
Sep 24

Amphastar CFO William J. Peters Sells 4,139 Shares for $103,475

Reuters
·
Sep 24

Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool

GlobeNewswire
·
Sep 24

Teva Releases Q3 2026 Aide Memoire

THOMSON REUTERS
·
Sep 24

Aurora UK Alpha Updates Share Buyback and Voting Rights

TIPRANKS
·
Sep 24

Teva Enters Acceleration Phase of Transformation Supported by Multi-Year Launch Cycle, Oppenheimer Says

MT Newswires Live
·
Sep 24

Aurora Expects to End 2026 With 200 Driverless Trucks in Operation; Aims for Over 30,000 by 2030

MT Newswires Live
·
Sep 23

3 E Network Advances European AI Data Center Project Through Nordic Subsidiary Aurora Core Technology Oy

GlobeNewswire
·
Sep 23

Canopy Growth extends proxy voting deadline for annual general, special meeting

TIPRANKS
·
Sep 23

Dr. Reddy's Laboratories Falls Wednesday, Underperforms Market

Dow Jones
·
Sep 23

Celebrate the Mid-Autumn and National Day Holidays With Authentic Sichuan Cuisine From Sanyangcai

Deep News
·
Sep 23

Top Teva Insider Makes Massive Multi-Million Dollar Stock Move

TIPRANKS
·
Sep 23

Avecho Advances Phase III CBD Insomnia Trial Ahead of ASX SMIDcaps Presentation

TIPRANKS
·
Sep 23

Emp Metals Completes Commissioning of Project Aurora Demonstration Plant and Transitions to Full-Time Operations

TIPRANKS
·
Sep 22

AIM ImmunoTech Targets Q1 2027 Topline Data for Phase 2 Duripanc Trial of Ampligen Plus AstraZeneca’s Imfinzi in Pancreatic Cancer

Reuters
·
Sep 22